Impact BioMedical Inc. (IBO)

NYSEAMERICAN: IBO · Real-Time Price · USD

0.4100

+0.0092 (2.30%)

Mar 3, 2026, 4:00 PM EST - Market closed

Impact BioMedical Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '26 Mar 3, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	43	17	-	-	-	-
Enterprise Value	66	25	-	-	-	-
Last Close Price	0.41	1.45	-	-	-	-
PB Ratio	-	2.31	-	-	-	-
Debt / Equity Ratio	-2.58	1.23	0.43	0.31	0.31	0.03
Net Debt / Equity Ratio	-2.58	0.95	0.43	0.31	0.31	0.02
Net Debt / EBITDA Ratio	-7.32	-2.03	-3.00	-4.36	-6.02	-
Net Debt / FCF Ratio	-5.66	-1.75	-4.21	-3.97	-6.16	-1.10
Asset Turnover	0.00	-	-	0.00	-	-
Quick Ratio	0.00	0.20	0.01	0	0.00	0.07
Current Ratio	0.04	0.25	0.03	0.01	0.02	0.10
Return on Equity (ROE)	-346.99%	-139.55%	-14.46%	-19.99%	-4.52%	-3.89%
Return on Assets (ROA)	-7.68%	-6.54%	-5.53%	-4.13%	-3.81%	-2.32%
Return on Capital Employed (ROCE)	71.40%	-32.30%	-12.80%	-9.50%	-7.30%	-1.90%
Earnings Yield	-103.02%	-148.12%	-	-	-	-
FCF Yield	-9.42%	-23.49%	-	-	-	-
Buyback Yield / Dilution	80.23%	82.14%	14.54%	0.00%	-	-

Updated Nov 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q